SAMSUNG BIOLOGICS CO.,LTD.
A contract development and manufacturing organization for the biopharmaceutical industry.
207940 | KO
Overview
Corporate Details
- ISIN(s):
- KR7207940008
- LEI:
- Country:
- South Korea
- Address:
- 인천광역시 연수구 송도바이오대로 300, 인천광역시
- Website:
- https://samsungbiologics.com/
- Sector:
- Manufacturing
Description
Samsung Biologics is a fully integrated contract development and manufacturing organization (CDMO) that provides end-to-end services to the biopharmaceutical industry. The company offers a comprehensive suite of solutions covering the entire product lifecycle, from early-stage cell line and process development to large-scale commercial manufacturing of drug substances. Key services include analytical development, quality and biosafety testing, and aseptic fill/finish of drug products. Samsung Biologics also supports the development and manufacturing of new modalities, including antibody-drug conjugates (ADCs) and mRNA. Leveraging its large-scale, CGMP-compliant facilities, the company serves a global client base of pharmaceutical companies with tailored and flexible manufacturing solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-06-07 00:00 |
투자판단관련주요경영사항
|
Korean | HTML • 6.2 KB | ||
| 2022-05-31 00:00 |
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
|
Korean | HTML • 196.9 KB | ||
| 2022-05-31 00:00 |
기업지배구조보고서공시
|
Korean | HTML • 8.7 KB | ||
| 2022-05-30 00:00 |
최대주주등소유주식변동신고서
|
Korean | HTML • 31.4 KB | ||
| 2022-05-24 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 23.0 KB | ||
| 2022-05-24 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 21.4 KB | ||
| 2022-05-24 00:00 |
최대주주등소유주식변동신고서
|
Korean | HTML • 43.1 KB | ||
| 2022-05-20 00:00 |
[기재정정]유형자산취득결정
|
Korean | HTML • 12.5 KB | ||
| 2022-05-16 00:00 |
분기보고서 (2022.03)
|
Korean | HTML • 1.5 MB | ||
| 2022-05-06 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 23.0 KB | ||
| 2022-05-06 00:00 |
최대주주등소유주식변동신고서
|
Korean | HTML • 41.4 KB | ||
| 2022-05-04 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 21.4 KB | ||
| 2022-04-29 00:00 |
[기재정정]유형자산취득결정
|
Korean | HTML • 11.8 KB | ||
| 2022-04-27 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | HTML • 15.6 KB | ||
| 2022-04-25 00:00 |
최대주주등소유주식변동신고서
|
Korean | HTML • 31.4 KB |
Automate Your Workflow. Get a real-time feed of all SAMSUNG BIOLOGICS CO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SAMSUNG BIOLOGICS CO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SAMSUNG BIOLOGICS CO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
